Warning: This security is no longer trading.
defunct
Pain Therapeutics, Inc. (PTIE): Price and Financial Metrics
PTIE Price/Volume Stats
| Current price | $1.24 | 52-week high | $10.87 |
| Prev. close | $1.16 | 52-week low | $0.76 |
| Day low | $1.18 | Volume | 294,500 |
| Day high | $1.27 | Avg. volume | 285,037 |
| 50-day MA | $1.17 | Dividend yield | N/A |
| 200-day MA | $1.79 | Market Cap | 21.35M |
PTIE Stock Price Chart Interactive Chart >
Pain Therapeutics, Inc. (PTIE) Company Bio
Pain Therapeutics, Inc., a biopharmaceutical company, develops novel drugs in the United States. The companys lead drug candidate is REMOXY, a proprietary abuse-deterrent oral formulation of oxycodone for pain relief. It also develops FENROCK, a proprietary abuse-deterrent transdermal pain patch for pain relief; and PTI-125, a small molecule drug candidate to treat Alzheimers disease and other neurological disorders. The company was founded in 1998 and is based in Austin, Texas.
PTIE Price Returns
| 1-mo | N/A |
| 3-mo | N/A |
| 6-mo | N/A |
| 1-year | N/A |
| 3-year | N/A |
| 5-year | N/A |
| YTD | N/A |
| 2023 | N/A |
| 2022 | N/A |
| 2021 | N/A |
| 2020 | N/A |
| 2019 | N/A |
Loading social stream, please wait...